$Novavax(NVAX)$hold with diamond hand
$175-$200 is a rational price for NVAX, then up or down from there depending on outlook for rest of 2022 and 2023, this price is not a rational objective price based on projected cash flows of the company, which is fundamentally valuing the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
It take guts to carry on holding this stock. Nothing wrong with it but it keeps going lower. Investor are punishing it because it does not have FDA approval